| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S11255-017-1662-3 |
| P698 | PubMed publication ID | 28733767 |
| P50 | author | Sun-Seog Kweon | Q57691086 |
| P2093 | author name string | Ran Lee | |
| Min-Ho Shin | |||
| Young-Hoon Lee | |||
| Seong-Woo Choi | |||
| Hye-Ran Ahn | |||
| Hee-Nam Kim | |||
| P2860 | cites work | K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification | Q29547560 |
| Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. | Q30353189 | ||
| PTX3, A prototypical long pentraxin, is an early indicator of acute myocardial infarction in humans | Q33912738 | ||
| Long pentraxin PTX3 upregulates tissue factor expression in human endothelial cells: a novel link between vascular inflammation and clotting activation | Q34128052 | ||
| Associations of pentraxin-3 with cardiovascular events, incident heart failure, and mortality among persons with coronary heart disease: data from the Heart and Soul Study | Q34150807 | ||
| Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility | Q34403569 | ||
| Elevated circulating levels and tissue expression of pentraxin 3 in uremia: a reflection of endothelial dysfunction. | Q34713240 | ||
| Uric acid and pentraxin-3 levels are independently associated with coronary artery disease risk in patients with stage 2 and 3 kidney disease | Q34724967 | ||
| Soluble TWEAK and PTX3 in nondialysis CKD patients: impact on endothelial dysfunction and cardiovascular outcomes | Q34751855 | ||
| Mannheim intima-media thickness consensus. | Q35937841 | ||
| Association of Kidney Disease Measures with Cause-Specific Mortality: The Korean Heart Study | Q35993577 | ||
| Association between levels of pentraxin 3 and incidence of chronic kidney disease in the elderly | Q36533057 | ||
| Epidemiology of obesity and chronic kidney disease | Q36625282 | ||
| Mannheim carotid intima-media thickness consensus (2004-2006). An update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006. | Q36654798 | ||
| ADMA levels correlate with proteinuria, secondary amyloidosis, and endothelial dysfunction. | Q36677348 | ||
| Novel links between the long pentraxin 3, endothelial dysfunction, and albuminuria in early and advanced chronic kidney disease | Q36736700 | ||
| The prevalence of chronic kidney disease (CKD) and the associated factors to CKD in urban Korea: a population-based cross-sectional epidemiologic study | Q37078158 | ||
| Effect of renin angiotensin system blockade on pentraxin 3 levels in type-2 diabetic patients with proteinuria | Q37123175 | ||
| Associations of pentraxin 3 with cardiovascular disease and all-cause death: the Cardiovascular Health Study | Q37141153 | ||
| Clinical epidemiology of cardiovascular disease in chronic kidney disease | Q37768499 | ||
| The long pentraxin PTX3: a modulator of the immunoinflammatory response in atherosclerosis and cardiovascular diseases. | Q37775325 | ||
| Chronic kidney disease: a public health priority and harbinger of premature cardiovascular disease | Q37784542 | ||
| Biology of human pentraxin 3 (PTX3) in acute and chronic kidney disease | Q38084920 | ||
| Association of bone mineral density with albuminuria and estimated glomerular filtration rate: the Dong-gu Study. | Q38451016 | ||
| Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms | Q38776803 | ||
| Pentraxin-3 Attenuates Renal Damage in Diabetic Nephropathy by Promoting M2 Macrophage Differentiation | Q38901060 | ||
| National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification | Q39513412 | ||
| Cohort Profile: The Namwon Study and the Dong-gu Study | Q40098837 | ||
| Effects of cumulative smoking exposure and duration of smoking cessation on carotid artery structure. | Q43910488 | ||
| Plasma pentraxin 3 in patients with chronic kidney disease: associations with renal function, protein-energy wasting, cardiovascular disease, and mortality | Q44571381 | ||
| Long-term prognostic significance of pentraxin-3 in patients with acute myocardial infarction: 5-year prospective cohort study. | Q51595971 | ||
| How to improve duration and efficiency of the antiproteinuric response to Ramipril: RamiPROT-a prospective cohort study. | Q53235378 | ||
| Plasma Pentraxin3 Level Is Associated With Plaque Vulnerability Assessed by Optical Coherence Tomography in Patients With Coronary Artery Disease. | Q53242378 | ||
| Establishment of a High Sensitivity Plasma Assay for Human Pentraxin3 as a Marker for Unstable Angina Pectoris | Q56942761 | ||
| Accumulation of free adduct glycation, oxidation, and nitration products follows acute loss of renal function | Q60786554 | ||
| Plasma sTWEAK and PTX3: New determinant tools of cardiovascular outcome also in patients with CKD | Q83726413 | ||
| [Is it feasible to improve the duration and the efficiency of Ramipril anti-proteinuric response?] | Q95604057 | ||
| P433 | issue | 11 | |
| P921 | main subject | chronic renal insufficiency | Q736715 |
| P304 | page(s) | 2027-2033 | |
| P577 | publication date | 2017-07-21 | |
| P1433 | published in | International Urology and Nephrology | Q15763616 |
| P1476 | title | Relationship between plasma pentraxin 3 level and risk of chronic kidney disease in the Korean elderly: the Dong-gu study. | |
| P478 | volume | 49 |
| Q89509365 | Aerobic Training Down-Regulates Pentraxin 3 and Pentraxin 3/Toll-Like Receptor 4 Ratio, Irrespective of Oxidative Stress Response, in Elderly Subjects | cites work | P2860 |
Search more.